[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366873-105":59,"doc-detail-366873-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-driven-computational-framework-for-cancer-molecular-subtype-classification-comparative-analysis","Multi-omics driven computational framework for cancer molecular subtype classification - Comparative analysis","","Cancer molecular subtype classification is a core part of precision oncology, informing prognosis and targeted therapy. Despite increasing AI use, results remain limited by non-standardized datasets, heterogeneous omics modalities, and inconsistent evaluation metrics. The study compares 35 AI classifiers across 153 datasets covering 8 omics modalities and 20 cancers, addressing six research questions. Findings identify which modality configurations and model types maximize macro-accuracy and improve reproducibility and comparability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-driven-computational-framework-for-cancer-molecular-subtype-classification-comparative-analysis/366873/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-driven-computational-framework-for-cancer-molecular-subtype-classification-comparative-analysis/366873.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cancer molecular subtype classification important in precision oncology?","Question",{"text":112,"@type":113},"It supports prognosis assessment and helps guide targeted therapies. It also addresses the fact that cancers that look similar can behave differently across patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What main challenges limit current AI classifiers for subtype prediction?",{"text":117,"@type":113},"Non-standardized dataset configurations, diverse omics modalities, and inconsistent evaluation measures reduce comparability, reproducibility, and generalizability across cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which models and dataset characteristics tend to perform best according to the study?",{"text":121,"@type":113},"Traditional ML models (e.g., SVM, XGB, HGB) perform best on small, low-dimensional datasets, while deep learning models (e.g., ResNet18, CNN, NN, MLP) excel on large, high-dimensional datasets. DL classifiers show superior macro-accuracy in most cancers compared to ML.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366873,1790468377,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMulti-omics driven computational framework for cancer molecular subtype classification  \nAhtisham Fazeel Abbasi1,2􀀍, Muhammad Sajjad1,3, Muhammad NabeelAsim2,4, Sebastian Vollmer1,3,4 & Andreas Dengel1,2,4  \nCancer molecular subtype classification is an essential component of precision oncology which provides insights into cancer prognosis and guides targeted therapy. Despite the growing applications of  \nAI for cancer molecular subtype classification, challenges persist due to non-standardized dataset configurations, diverse omics modalities, and inconsistent evaluation measures. These issues limit the comparability, reproducibility, and generalizability of AI classifiers across different cancers and hinder the development of robust and accurate AI-driven tools. This study performs comparative analyses of 35 unique AI classifiers across 153 datasets, covering 8 omics modalities and 20 different cancers. Particularly, it investigates 6 different research questions, and based on comprehensive performance analyses of the 35 AI classifiers it elucidates the research questions with the following answers: (i) out of 17 different configurations for 5 out of the 8 tested omics modalities, RPPA (RPPA), Gistic2-all-data-by-genes (CNV), HM27 (Meth), and HiSeqV2-exon (Exon) configurations consistently yield better performance; (ii) in terms of 8 omics modalities, RNASeq, miRNA, CNV, and Exon generally achieve higher macro-accuracy (MACC) compared to Meth., Array, SNP and RPPA; (iii) SNP and RPPA modalities are prone to biases due to technical noise; (iv) traditional machine learning (ML) models (SVM, XGB, HGB) perform best on small and low-dimensional datasets, while deep learning (DL) models (ResNet18, CNN, NN, MLP) excel on large and high-dimensional datasets; (v) SVM achieves the highest mean MACC across all classifiers, with NN, ResNet18, DEEPGENE, and MLP also demonstrate strong performance; and (vi) DL classifiers show superior MACC as compared to ML classifiers in 12 out of 20 cancers. The findings offer key insights to guide the development of standardized, robust, and efficient AI-driven pipelines for cancer molecular subtype classification. This study enhances reproducibility and facilitates better comparison across AI methods, ultimately advancing precision oncology.  \nCancer is a group of diseases characterized by uncontrolled growth and spread of cells that can invade nearby tissues and other parts of the body (metastasis)1. According to the World Health Organization (WHO), more than 200 cancers2 have been identified with different characteristics, causes, and symptoms3. These cancers are categorized based on their origin, structure, and molecular characteristics into several major groups: Carcinomas, Sarcomas, Leukemias, Lymphomas, Neuroendocrine Tumors, and mixed Tumors that vary significantly in terms of origin and mechanism of action4.  \nCancers claim almost 10 million lives each year, and around 19.3 million new cancer cases are diagnosed, making it the second most common cause of death worldwide5. These high mortality rates and diagnostic challenges stem from its complex nature and molecular diversity since each cancer presents unique characteristics that complicate diagnosis and treatment6. For instance, as multiple cancers are asymptomatic in their early stages, symptoms often mimic other common conditions, and each cancer can have various molecular subtypes requiring distinct treatment approaches. Moreover, the same cancer type can behave differently in individual patients7 which highlights the critical need to go beyond cancer detection and address the complexities of understanding molecular subtypes and behaviors.  \n1Department of Computer Science, Rhineland Palatinate Technical University of Kaiserslautern-Landau (RPTU), Kaiserslautern 67663, Rhineland-Palatinate, Germany. 2Smart Data and Knowledge Services (SDS), German Research Cent","cbCaidmiUQXSqjcS","https://ap.wps.com/l/cbCaidmiUQXSqjcS","pdf",7737863,23,"English","# Introduction\n## Precision oncology and the need for subtype classification\n## Challenges in AI-based classification across datasets and omics\n# Study design and comparative analysis\n## Coverage of datasets, cancers, omics modalities, and classifiers\n## Key research questions and performance findings\n# Background on cancer and molecular subtypes\n## Cancer burden, molecular diversity, and subtype complexity\n## TCGA and traditional approaches to subtype identification","[{\"question\":\"Why is cancer molecular subtype classification important in precision oncology?\",\"answer\":\"It supports prognosis assessment and helps guide targeted therapies. It also addresses the fact that cancers that look similar can behave differently across patients.\"},{\"question\":\"What main challenges limit current AI classifiers for subtype prediction?\",\"answer\":\"Non-standardized dataset configurations, diverse omics modalities, and inconsistent evaluation measures reduce comparability, reproducibility, and generalizability across cancers.\"},{\"question\":\"Which models and dataset characteristics tend to perform best according to the study?\",\"answer\":\"Traditional ML models (e.g., SVM, XGB, HGB) perform best on small, low-dimensional datasets, while deep learning models (e.g., ResNet18, CNN, NN, MLP) excel on large, high-dimensional datasets. DL classifiers show superior macro-accuracy in most cancers compared to ML.\"}]","Multi-omics driven computational framework for cancer molecular subtype classification - Comparative analysis | PDF",1790168055,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8ed553aebfcefe0f58660d2e4a5cec3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b571f6db302886a1af6f31eb144b3de8.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77054ab5b73ee6c7ee9c3fb0655b5a15.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/855a44063c66b414d6f0f4359db6b65b.webp",980,1287]